Mitsubishi Tanabe Pharma America to Showcase New Research Findings in ALS at 2025 MDA Clinical and Scientific Conference
Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral sclerosis (ALS) at the 2025 Muscular Dystrophy Association ...
Reuters1mon
Bain to buy Japan's Mitsubishi Tanabe Pharma for $3.4 billion
TOKYO, Feb 7 (Reuters) - U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of ...
The Business Journals1mon
Bain Capital buys Japanese pharma for $3.3B
Bain Capital is making its latest biotech bid in Japan, where it plans to acquire Mitsubishi Tanabe Pharma Corp. The Boston-based private investment firm is buying Tanabe Pharma from Mitsubishi ...
Business Wire1mon
Bain Capital to Acquire Mitsubishi Tanabe Pharma Corporation
TOKYO & BOSTON--(BUSINESS WIRE)--Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation ...
The Victoria Advocate1mon
Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Disease Progression with RADICAVA® (edaravone) in ALS
You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...
The Pharma Letter8d
The Pharma Letter M&A roundup - February 2025
Mitsubishi Tanabe Pharma and bluebird bio were both bought by investors during the month, while private equity firms ...
Morningstar2d
Mitsubishi Tanabe Pharma America to Showcase New Research Findings in ALS at 2025 MDA Clinical and Scientific Conference
JERSEY CITY, N.J., March 12, 2025 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of eleven abstracts covering research in amyotrophic lateral ...